Inhibitors of fibroblast growth factor receptor kinases
US12331039B2 · kind B2 · utility
0Cited by
13References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Dec 3, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.